Outcomes of transoral laser microsurgery and transoral robotic surgery in oropharyngeal squamous cell carcinoma |
| |
| Authors: | Matti Sievert Miguel Goncalves Ali Zbidat Maximilian Traxdorf Sarina K. Mueller Heinrich Iro Antoniu-Oreste Gostian |
| |
| Affiliation: | 1. Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan;2. Department of Otorhinolaryngology, Ota General Hospital, Kanagawa, Japan;1. Kitajima ENT Clinic, 1-15-15 Tagara Nerima-ku, Tokyo 179-0073, Japan;2. Department of Otolaryngology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo 160-0023, Japan;3. Department of Otolaryngology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa 216-8511, Japan;1. Orofacial Pain Clinic of the Dental School of University of Athens, Greece;2. Dental School of University of Athens,Greece;1. Jichi Medical University Saitama Medical Center, Department of Otolaryngology, 1-847 Amanuma-cho, Omiya-ku, Saitama 330-8503, Japan;2. Tokyo Kita Medical Center, Department of Otolaryngology, 4-17-56 Akabanedai, Kita-ku, Tokyo 115-0053, Japan;1. Health Science University Zeynep Kamil Health Practice and Research Center, Child Health and Diseases Clinic, Uskudar, Istanbul, Turkey;2. Sancaktepe ?ehit Prof. Dr. ?lhan Varank Training and Research Hospital, Ear, Nose and Throat Clinic, Istanbul, Turkey;1. Department of Otorhinolaryngology-Head and Neck Surgery, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea;2. Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea |
| |
| Abstract: | ![]()
ObjectiveTransoral robotic surgery (TORS) has evolved to a standard therapy modality for oropharyngeal carcinoma, especially in T1/ T2 tumors involving the base of the tongue due to its advantages compared with open surgery. However, knowledge about its benefits compared with transoral laser microsurgery (TLM) are scarce. This study compares oncological and functional results of TLM or TORS in the treatment of oropharyngeal squamous cell carcinoma (OPSCC).MethodsThis retrospective analysis comprises all patients with OPSCC treated with TLM (n = 30) or TORS (n = 24) between April 2003 and May 2018 (follow-up 43 ± 38.3 months). Both treatment groups (TLM and TORS) were comparable in terms of the stage of the disease, prognosis-determining factors, and adjuvant therapy modalities.ResultsThere were no significant differences regarding to the resection status (p = 0.272), the rate of local- (p = 0.834) and distant- recurrence (p = 0.416), with a disease-free survival of 86.7 % and 87.5 %, respectively (p = 0.892). In addition, we could not confirm any differences regarding to operating time (p = 0.860), intraoperative blood loss (p = 0.660), inpatient stay (p = 0.585) and postoperative bleeding rate (p = 0.245). The frequency of tracheostomy and percutaneous endoscopic gastrostomy between both groups is comparable, with a longer duration of tube feeding in patients who have received TLM (p = 0.030).ConclusionIn conclusion, TORS allows for similar oncological outcomes compared with TLM at comparable perioperative risks. The postoperative swallowing function may benefit from TORS. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
